Skip to main content
Caplight Logo









Medchart

Medchart

Private
Toronto, OntarioHealthcare & Life Scienceshttps://medchart.com/

Last Round

Series A

Dec 1, 2020

Total Funding Raised

$26.06M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Medchart is a healthtech company that provides a privacy-compliant platform designed to automate medical record release and consent capture.

Sector

Healthcare & Life Sciences

Verticals

Legal Tech, InsurTech, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical record retrievalhealth information exchangehealthcare data platformlegal techinsurtechrelease of informationROIhealthcare APIPlaid for health datapatient consent managementHIPAA complianceclinical trial dataAI medical data analysisEHR accessunstructured data extractionsmart OCRusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medchart Comparables

Compare Medchart with similar companies based on industry and business-model similarity.

Medchart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Codes Health
80%
YoCierge
79%
ChartSquad
77%

Medchart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 1, 2020
Series ADec 1, 2020
GrantJan 4, 2018

Key People

Founding team and executive leadership

James Bateman

CEO Co-Founder

Founding Team

Medchart Investors

Notable investors and investment history

Medchart investors
InvestorRounds
Crosslink CapitalSeries A
Stanford Law SchoolSeries A
iGan PartnersSeries A, Seed
Silicon Valley BankSeries A
Vast VenturesSeries A
Golden VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 125, 31.3x the trailing average.

  • Jul 13, 2026

    Open roles increased from 0 to 12, representing 27% of headcount.

Medchart Filings

Explore SEC and related filing metadata, where available.

Medchart filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medchart's valuation, stock price, and market status.

Is Medchart a public or private company?

Medchart is a private company.

What is the current stock price of Medchart?

Medchart is a private company with no public stock price. No recent secondary market data is available.

How much is Medchart worth (valuation)?

Valuation information for Medchart is not publicly available.

Can I buy Medchart stock?

Medchart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medchart's last funding round?

Medchart's most recent funding round was Series A on December 1, 2020.

Who are the main investors in Medchart?

Key investors in Medchart include Crosslink Capital, Golden Ventures.

Will Medchart IPO soon?

No public IPO plans have been announced for Medchart.

How can I track Medchart secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medchart's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range45
Year Founded2015
Last FundingDec 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?